Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC5R | P33032 | 5/20 | 0.45 |
| ▸ | MC4R | P32245 | 3/20 | 0.45 |
| ▸ | MC3R | P41968 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.40 |
| ▸ | MC1R | Q01726 | 2/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | NPY1R | P25929 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9609732 | 0.93 | MC5R (0.44) | MC5RMC4RMC3RMAPK1MC1R | |
| SCHEMBL9609725 | 0.89 | MC5R (0.57) | MC5RMC4RMC3RMAPK1MC1R | |
| SCHEMBL9609702 | 0.81 | HPRT1 (0.33) | MAPK1 | |
| SCHEMBL9609695 | 0.81 | TERT (0.46) | MC5RMC4RMC3RMC1RBCHE | |
| SCHEMBL9609753 | 0.80 | MC4R (0.40) | MC5RMC4RMC3RMC1RBCHE | |
| SCHEMBL136399 | 0.78 | MAOA (0.55) | BCHE | |
| SCHEMBL9609728 | 0.76 | CNR2 (0.50) | MC5RMC4RBCHEACHEHDAC3 | |
| SCHEMBL16921900 | 0.76 | ABCB1 (0.37) | SLC2A1 | |
| SCHEMBL4135709 | 0.75 | CHRM2 (0.54) | BCHE | |
| Ethylene SCHEMBL27935498 | 0.75 | MAOA (0.51) | BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921243-B2 | Fabrics comprising a photocatalyst to produce singlet oxygen from ambient oxygen | VENTANA RESEARCH CORPORATION | 2014-12-30 | — | — | US | disclosed |
| US-8481446-B2 | Chemically-resistant coating composition | VENTANA RESEARCH CORPORATION | 2013-07-09 | — | — | US | disclosed |
| US-20120135651-A1 | Fabrics Comprising a Photocatalyst to Produce Singlet Oxygen from Ambient Oxygen | VENTANA RESEARCH CORPORATION | 2012-05-31 | — | — | US | disclosed |
| US-20100279850-A1 | CHEMICALLY-RESISTANT COATING COMPOSITION | VENTANA RESEARCH CORPORATION | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279850-A1 | CHEMICALLY-RESISTANT COATING COMPOSITION | DNMT1, VCL, DNMT3L | MC5R 4767/4885MC4R 4396/4885MC3R 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.